Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-11

FDA Approved: SUMATRIPTAN — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for sumatriptan submitted by Eugia US LLC under the ANDA program. The approval pertains to an updated/modified sumatript…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)